Arvinas Inc. Public Market Comparables
Find the most relevant public market comparables for Arvinas Inc., including EV/Revenue and EV/EBITDA multiples to help you make informed investment decisions.
Company Overview
Arvinas is a clinical-stage biopharmaceutical company focused on developing new therapeutics for cancers and other difficult-to-treat diseases. Their proprietary PROTAC® protein degraders harness the body's natural protein disposal system to degrade disease-causing proteins.
Business Model
Discovery, development, and commercialization of protein degradation therapies using their proprietary PROTAC® platform.
Target Customers
Patients with cancer and other difficult-to-treat diseases; pharmaceutical companies seeking collaborations.
Specific Focus
Targeted protein degradation therapies
Location
New Haven, Connecticut
CEO
John G. Houston, Ph.D.
Industry
Life sciences
Sub Sector
Biotechnology
3yr Revenue Growth
203%
Website
Public Market Comparables
Below are the key valuation metrics for companies similar to Arvinas Inc. in the Pharmaceuticals & Biotech sector. These metrics can help you understand how the market values companies with similar business models and growth profiles.
Looking for a comprehensive compset for Arvinas Inc.? Our platform provides detailed analysis of Arvinas Inc.'s competitive landscape, including financial metrics, growth trends, and market positioning. Get access to the full Arvinas Inc. compset by trying our platform today.
EV/Revenue Multiple
Min
0.0x
Median
0.0x
Max
00.0x
Unlock actual values by trying our platform
View Full DetailsEV/EBITDA Multiple
Min
00.0x
Median
00.0x
Max
00.0x
Unlock actual values by trying our platform
View Full Details
Unlock the Full Arvinas Inc. Compset
As a leading player in the Life sciences industry within the Pharmaceuticals & Biotech sector, Arvinas Inc. operates in the specialized Biotechnology sub-sector. Understanding how Arvinas Inc. compares to its public market comps is essential for accurate valuation and strategic decision-making.
Our comprehensive analysis includes detailed comparables (compsets) featuring similar companies in the Biotechnology space, with complete financial metrics, growth trajectories, and competitive positioning insights that go beyond the surface-level data shown above.
Other Interesting Companies
Nurix Therapeutics, Inc.
Biotechnology & Drugs • Life sciences
Nurix Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted protein degradation medicines to improve treatment options for patients with cancer and inflammatory diseases. Their approach involves modulating cellular protein levels using oral, small molecule therapies.
TicketOS
Software • Software & services
TicketOS is a leading ticket management platform that empowers businesses to manage their corporate sports and entertainment tickets effortlessly. With cutting-edge technology and customizable solutions, TicketOS helps organizations maximize ticket utilization, enhance employee experiences, and achieve the best return on investment. It provides a cloud-based solution for managing corporate event tickets, luxury suites, and hospitality passes, integrating marketing, sales, and finance departments.
Digital Turbine, Inc.
Technology • Software & services
Digital Turbine, Inc. provides an independent mobile growth platform offering end-to-end products and solutions to all participants in the mobile application ecosystem. This includes enabling brand discovery and advertising, user acquisition and engagement, and operational efficiency for advertisers. They also provide monetization opportunities for OEMs, carriers, and app publishers and developers. Their operating segments include On Device Solutions (ODS) and App Growth Platform (AGP).
Get Your Custom Comparable Analysis
Need a more detailed analysis of Arvinas Inc. and its public market comparables? Our platform provides comprehensive valuation metrics, growth analysis, and more.
Try CompsetFinder Free